Truckee Applied Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Truckee Applied Genomics's estimated annual revenue is currently $930k per year.
- Truckee Applied Genomics's estimated revenue per employee is $155,000
Employee Data
- Truckee Applied Genomics has 6 Employees.
- Truckee Applied Genomics grew their employee count by 20% last year.
Truckee Applied Genomics's People
| Name | Title | Email/Phone |
|---|
Truckee Applied Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 50% | N/A | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $3.5M | 16 | -11% | $18M | N/A |
#4 | $1.1M | 7 | -22% | N/A | N/A |
#5 | $14.4M | 93 | 27% | N/A | N/A |
#6 | $3.7M | 24 | -11% | N/A | N/A |
#7 | $9.6M | 62 | 3% | N/A | N/A |
#8 | $300M | 243 | -14% | $53M | N/A |
#9 | $3.1M | 20 | 18% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Truckee Applied Genomics?
We provide patented reagents to improve molecular tests of tissues and pathogens. Developed and manufactured in the USA. TAG-NGPMâ„¢ - Next Generation Pathogen Media - Designed to better preserve RNA fragments in a variety of pathogen samples. Ideal as a Viral Transport Media (VTM) currently used in SARS-CoV-2 sample collection in COVID-19 testing. TAG-1 | Non-Toxic Tumor Tissue Stabilization Directly Replacing Formalin * No cross-linking of cellular proteins * Excellent preservation of tissue morphology * Strong protection of cell surface antigenic components * Protection of nuclear contents including nucleic acids ** TAG-1 is a Class 1 General Reagent pursuant to 21 CFR 864.4010
keywords:N/A
N/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Reno
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.4M | 6 | 20% | N/A |
#3 | $0.5M | 6 | 0% | N/A |
#4 | $0.8M | 6 | 0% | N/A |
#5 | $0.4M | 6 | N/A | N/A |